Loading
Dexterra Group Inc. Stock: price and insider trades · Canada
Insider Decl.
298
Thresholds
n/a
Buy Volume
€1M
66 ops. · all time
Sell Volume
€1M
12 ops. · all time
Who traded when
BuySaleDenise Achonu7 buys
David Lloyd Johnston5 buys
Mark Alan Becker4 buys
Mary Garden1 buy2 sales
Antonia Rossi1 sale
Jeffrey Litchfield1 buy
Analyst consensus: bullish or bearish?
Analysts rate Dexterra Group Inc. Buy (bullish), based on 8 analysts. Average price target: CA$19.94.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,151 of 26,250 companies
53.4
score / 100
Value58
Quality49
FCF yld6.8%
Earn yld3.7%
EV/EBITDA12.1x
ROE15%
Gross mgn18%
Net mgn3.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$17.34
Analyst consensus
8 analystsBuy
CA$15.50Target CA$19.94(+15%)CA$25.00
Income statement
RevenueCA$1B
Gross profitCA$186.6M18% margin
EBITDACA$108.4M10% margin
Net incomeCA$40.5M4.0% margin
Valuation
PER (trailing)24.8x
PER (forward)14.9x
P/Book3.6x
Beta0.50
Balance sheet & cash
Market capCA$1.1B
Total debtCA$223.3M
Free Cash FlowCA$74.1M
Debt / Equity76%
Profitability & ownership
ROE15.4%
ROA6.5%
% insiders52.7%
% institutions10.7%
Last declaration on 21 October 2026
Declarations298 total
20,579 shares@ CA$8.500.016% mcap13.5% of flowCommon SharesTSXSEDI:4793421
55,118 shares@ CA$8.5036.1% of flowOptionsTSXSEDI:4793420
2,705 shares@ CA$5.870.0014% mcap4.0% of flowCommon SharesTSXSEDI:4789944
11,792 shares@ CA$5.8717.5% of flowOptionsTSXSEDI:4789943
16,723 shares@ CA$5.870.0088% mcap24.9% of flowCommon SharesTSXSEDI:4789941
34,071 shares@ CA$5.8750.7% of flowOptionsTSXSEDI:4789940
6,910 shares@ CA$8.500.0053% mcap27.8% of flowCommon SharesTSXSEDI:4789933
17,913 shares@ CA$8.5072.2% of flowOptionsTSXSEDI:4789931
39,700 sharesCommon SharesTSXSEDI:4788797
900 shares@ CA$13.730.0011% mcap0.8% of flowCommon SharesTSXSEDI:4788796
1,900 shares@ CA$13.750.0024% mcap1.6% of flowCommon SharesTSXSEDI:4788795
8,800 shares@ CA$13.74260.011% mcap7.5% of flowCommon SharesTSXSEDI:4788794
8,100 shares@ CA$13.64940.010% mcap6.9% of flowCommon SharesTSXSEDI:4788792
10,000 shares@ CA$13.57550.012% mcap8.4% of flowCommon SharesTSXSEDI:4788791
19,923 shares@ CA$5.950.012% mcap21.6% of flowCommon SharesTSXSEDI:4782707
41,227 shares@ CA$5.9544.7% of flowOptionsTSXSEDI:4782705
11,678 shares@ CA$5.350.0062% mcap11.4% of flowCommon SharesTSXSEDI:4782696
22,846 shares@ CA$5.3522.3% of flowOptionsTSXSEDI:4782691
78,600 sharesCommon SharesTSXSEDI:4775452
10,000 shares@ CA$13.7220.012% mcap8.5% of flowCommon SharesTSXSEDI:4775450
10,000 shares@ CA$13.66310.012% mcap8.5% of flowCommon SharesTSXSEDI:4775448
8,900 shares@ CA$13.70080.011% mcap7.5% of flowCommon SharesTSXSEDI:4775447
10,000 shares@ CA$13.5580.012% mcap8.4% of flowCommon SharesTSXSEDI:4775446
10,000 shares@ CA$13.45090.012% mcap8.3% of flowCommon SharesTSXSEDI:4775445
9,800 shares@ CA$13.37790.012% mcap8.1% of flowCommon SharesTSXSEDI:4775444
25 of 298 declarations
About Dexterra Group Inc.
At Dexterra Group Inc., a Canadian industrials company valued at CAD 1.1 billion and 52.7% held by insiders, purchases number 40 worth EUR 842,933 (median EUR 14,056), against 7 sales worth EUR 967,843 (median EUR 31,061). One sale weighs almost all of it: EUR 802,979, by Roderick William Graham (director) on March 12, 2021. Mary Garden (director) then sold EUR 45,716 on January 13, 2025, and R. Drew Knight EUR 36,196 on August 27, 2021.
The largest purchases date from 2021 and 2024: R. William McFarland, EUR 105,966 on May 17, 2021, Simon Landy, EUR 93,819 on June 28, 2021, and Mark Alan Becker, EUR 73,945 on May 21, 2024. From May 17 to June 11, 2024, 8 insiders bought for EUR 324,300. Purchases are 85% of open-market trades.
Read moreShow less
The issuer itself files 17 of the 137 filings, with no purchase or sale; Jeffrey Litchfield also signs 17, Denise Achonu 16 and David Lloyd Johnston 14, 9 of them purchases. There are 39 option exercises. Annual volume climbs to 51 in 2025. The median publication delay is 3 days. No purchase or sale over the last twelve months, which hold 46 filings. The 28 purchases with a result have a 90-day median of 6.9%, with 86% positive (recorded past results, not a forecast).
